|
.
See Category: Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
ICD-10 (CM) Code and Descriptor
R94.8 |
Abnormal results of function studies of other organs and systems
|
R948 utilizaton on OPPS claims.*
Primary ICD10 Code |
ICD10 Position 2 |
ICD10 Position 3 |
ICD10 Position 4 |
ICD10 Position 5 |
ICD10 Position 6 |
ICD10 Position 7 |
ICD10 Position 8 |
ICD10 Position 9 |
ICD10 Position 10 |
18.92%
|
27.11%
|
19.16%
|
11.72%
|
7.30%
|
4.88%
|
3.29%
|
2.18%
|
1.37%
|
0.96%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for R94.8*:
CPT |
Description |
Number of Claims |
Sum Performed |
36415
|
COLL VENOUS BLD VENIPUNCTURE |
775
|
781
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
755
|
757
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
473
|
473
|
80053
|
COMPREHEN METABOLIC PANEL |
441
|
441
|
A9503
|
TC99M MEDRONATE |
428
|
428
|
88305
|
TISSUE EXAM BY PATHOLOGIST |
389
|
596
|
Q9967
|
LOCM 300-399MG/ML IODINE,1ML |
365
|
32,163
|
78306
|
BONE IMAGING WHOLE BODY |
362
|
362
|
G1004
|
CDSM NDSC |
315
|
371
|
J2704
|
INJ, PROPOFOL, 10 MG |
244
|
7,975
|
84153
|
ASSAY OF PSA TOTAL |
207
|
207
|
74177
|
CT ABD & PELVIS W/CONTRAST |
202
|
202
|
82565
|
ASSAY OF CREATININE |
172
|
172
|
80048
|
METABOLIC PANEL TOTAL CA |
153
|
153
|
J3010
|
FENTANYL CITRATE INJECTION |
144
|
185
|
84443
|
ASSAY THYROID STIM HORMONE |
138
|
138
|
J2250
|
INJ MIDAZOLAM HYDROCHLORIDE |
136
|
405
|
88342
|
IMHCHEM/IMCYTCHM 1ST ANTB |
136
|
146
|
80061
|
LIPID PANEL |
127
|
127
|
71260
|
CT THORAX DX C+ |
126
|
126
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
R94.8 related to the following DRG Codes:
695-696
|